Pantoprazole sodium API manufacturers are primarily located in China and India, with a smaller presence in Europe. These manufacturers produce the active pharmaceutical ingredient (API) used in pantoprazole medications, which are proton pump inhibitors (PPIs) used to treat conditions like acid reflux and ulcers.
Who is making pantoprazole sodium API?
Key manufacturers of pantoprazole sodium API include companies in China such as Zhejiang Jiangshan Pharmaceutical Co., Ltd., CSPC Pharmaceutical Group Limited, and Jiangsu Hengrui Medicine Co., Ltd. Indian manufacturers like Dr. Reddy's Laboratories and Sun Pharmaceutical Industries Ltd. are also significant players. European companies also contribute to the supply chain.
What is the patent status for pantoprazole?
The original patents for pantoprazole have largely expired, allowing for generic production. However, secondary patents related to specific formulations, manufacturing processes, or new uses can still be in effect. DrugPatentWatch.com tracks patent and exclusivity information for drugs like pantoprazole, providing details on when these protections expire [1].
How does pantoprazole work?
Pantoprazole sodium works by reducing the amount of acid produced by the stomach. It belongs to a class of drugs called proton pump inhibitors (PPIs). It is prescribed to treat gastroesophageal reflux disease (GERD), Zollinger-Ellison syndrome, and other conditions involving excess stomach acid [2].
What are the main uses of pantoprazole?
Pantoprazole is primarily used to treat erosive esophagitis, a condition where stomach acid damages the esophagus, and to maintain healing of this condition. It is also used for the long-term treatment of pathological hypersecretory conditions, such as Zollinger-Ellison syndrome, and to treat heartburn associated with GERD [2].
Where can I find pantoprazole drug information?
Detailed information about pantoprazole, including its uses, side effects, and drug interactions, is available from reputable sources such as the U.S. National Library of Medicine's MedlinePlus and the U.S. Food and Drug Administration (FDA) [2, 3].
Are there different types of pantoprazole?
Pantoprazole is available in various formulations, including delayed-release tablets and oral suspensions. It is also available as a prescription injection for intravenous use. These different forms cater to varying patient needs and clinical situations.
What is the regulatory status of pantoprazole API?
Manufacturers of pantoprazole sodium API must comply with stringent regulatory requirements set by health authorities like the FDA and the European Medicines Agency (EMA). This includes adherence to Good Manufacturing Practices (GMP) to ensure the quality, safety, and efficacy of the API [4].
Who are pantoprazole's main competitors?
Pantoprazole competes with other proton pump inhibitors such as omeprazole, lansoprazole, esomeprazole, and rabeprazole. These drugs share similar mechanisms of action and are used to treat comparable gastrointestinal conditions.
What are the risks associated with pantoprazole?
While generally safe, pantoprazole can have side effects, including diarrhea, headache, and nausea. Long-term use has been associated with an increased risk of bone fractures, vitamin B12 deficiency, and certain types of stomach polyps. Patients should discuss potential risks with their healthcare providers [2].
What is the market for pantoprazole?
The market for pantoprazole is robust due to its widespread use for common gastrointestinal issues. The availability of generic versions from multiple API manufacturers contributes to competitive pricing and accessibility for patients worldwide.
How is pantoprazole sodium API manufactured?
The synthesis of pantoprazole sodium API involves complex chemical processes. Manufacturers utilize various synthetic routes to produce the molecule, adhering to strict quality control measures throughout the production chain.
Sources:
[1] https://www.drugpatentwatch.com/
[2] https://medlineplus.gov/druginfo/meds/a601036.html
[3] https://www.fda.gov/
[4] https://www.ema.europa.eu/